These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36890852)

  • 1. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study.
    van Eeden C; Mohazab N; Redmond D; Yacyshyn E; Clifford A; Russell AS; Osman MS; Cohen Tervaert JW
    Lancet Reg Health Am; 2023 Apr; 20():100460. PubMed ID: 36890852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploratory study into the relationship between the symptoms of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) and fibromyalgia (FM) using a quasiexperimental design.
    Mckay PG; Walker H; Martin CR; Fleming M
    BMJ Open; 2021 Feb; 11(2):e041947. PubMed ID: 33526500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
    Bulanov NM; Makarov EA; Shchegoleva EM; Zykova AS; Vinogradova ES; Novikov PI; Lysenko Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2018 Jun; 90(6):15-21. PubMed ID: 30701899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature.
    van Eeden C; Osman MS; Cohen Tervaert JW
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1049-1070. PubMed ID: 36045606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
    Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S
    J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic fatigue syndrome (CFS)/Myalgic Encephalomyelitis (ME) and Fibromyalgia (FM): the foundation of a relationship.
    Mckay PG; Martin CR; Walker H; Fleming M
    Br J Pain; 2021 Feb; 15(1):26-39. PubMed ID: 33633851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between myeloperoxidase-antineutrophil cytoplasmic autoantibody (ANCA) and proteinase 3-ANCA associated vasculitis: A retrospective study from a single center in China.
    Wu T; Shen C; Zhong Y; Ooi JD; Zhou YO; Chen JB; Meng T; Xiao Z; Lin W; Ao X; Xiao X; Zhou Q; Xiao P
    Exp Ther Med; 2021 Jun; 21(6):561. PubMed ID: 33850533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis.
    Alba MA; Jennette JC; Hu Y; Poulton CJ; Blazek L; Derebail VK; Falk RJ; Hogan SL
    Kidney Int Rep; 2022 Dec; 7(12):2676-2690. PubMed ID: 36506241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
    Puéchal X; Iudici M; Pagnoux C; Cohen P; Hamidou M; Aouba A; Lifermann F; Ruivard M; Aumaître O; Bonnotte B; Maurier F; Le Gallou T; Hachulla E; Karras A; Khouatra C; Jourde-Chiche N; Viallard JF; Blanchard-Delaunay C; Godmer P; Le Quellec A; Quéméneur T; de Moreuil C; Mouthon L; Terrier B; Guillevin L;
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35296533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study.
    Hong Y; Shi P; Liu X; Yang L; Li K; Xu F; Liang S; Liu Z; Zhang H; Chen Y; Hu W
    Clin Rheumatol; 2019 Jun; 38(6):1665-1673. PubMed ID: 30737591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis.
    Damoiseaux J; Steller U; Buschtez M; Vaessen M; Rosemann A; van Paassen P; Stöcker W; Fechner K; Tervaert JW
    J Immunol Methods; 2009 Aug; 348(1-2):67-73. PubMed ID: 19615371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation.
    Ebert M; Jerke U; Eulenberg-Gustavus C; Kling L; Jenne D; Kirchner M; Mertins P; Bieringer M; Elitok S; Eckardt KU; Schreiber A; Salama AD; Kettritz R
    J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36125911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.